VOYA Investment Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,010
| Closed | -$590K | – | 2889 |
|
|
2023
Q4 | $590K | Sell |
11,010
-185
| -2% | -$9.36K | ﹤0.01% | 1980 |
|
|
2023
Q3 | $656K | Buy |
11,195
+16
| +0.1% | +$1K | ﹤0.01% | 1888 |
|
|
2023
Q2 | $705K | Buy |
11,179
+212
| +2% | +$13.5K | ﹤0.01% | 1881 |
|
|
2023
Q1 | $690K | Hold |
10,967
| – | – | ﹤0.01% | 1862 |
|
|
2022
Q4 | $583K | Hold |
10,967
| – | – | ﹤0.01% | 1946 |
|
|
2022
Q3 | $615K | Buy |
10,967
+2
| +0% | +$132 | ﹤0.01% | 1903 |
|
|
2022
Q2 | $793K | Sell |
10,965
-386
| -3% | -$28.7K | ﹤0.01% | 1559 |
|
|
2022
Q1 | $901K | Buy |
11,351
+150
| +1% | +$13.5K | ﹤0.01% | 1538 |
|
|
2021
Q4 | $1.13M | Sell |
11,201
-253
| -2% | -$25.2K | ﹤0.01% | 1464 |
|
|
2021
Q3 | $1.06M | Buy |
11,454
+355
| +3% | +$34.2K | ﹤0.01% | 1533 |
|
|
2021
Q2 | $1.14M | Sell |
11,099
-342
| -3% | -$34.3K | ﹤0.01% | 1549 |
|
|
2021
Q1 | $1.12M | Buy |
11,441
+2,483
| +28% | +$226K | ﹤0.01% | 1522 |
|
|
2020
Q4 | $691K | Buy |
8,958
+853
| +11% | +$66K | ﹤0.01% | 1720 |
|
|
2020
Q3 | $597K | Sell |
8,105
-363
| -4% | -$29.1K | ﹤0.01% | 1564 |
|
|
2020
Q2 | $622K | Sell |
8,468
-1,373
| -14% | -$108K | ﹤0.01% | 1517 |
|
|
2020
Q1 | $568K | Buy |
9,841
+3,354
| +52% | +$233K | ﹤0.01% | 1550 |
|
|
2019
Q4 | $510K | Buy |
6,487
+1,208
| +23% | +$89K | ﹤0.01% | 1878 |
|
|
2019
Q3 | $361K | Hold |
5,279
| – | – | ﹤0.01% | 1941 |
|
|
2019
Q2 | $419K | Buy |
5,279
+62
| +1% | +$4.92K | ﹤0.01% | 1896 |
|
|
2019
Q1 | $438K | Hold |
5,217
| – | – | ﹤0.01% | 1854 |
|
|
2018
Q4 | $614K | Buy |
5,217
+261
| +5% | +$30.2K | ﹤0.01% | 1594 |
|
|
2018
Q3 | $597K | Hold |
4,956
| – | – | ﹤0.01% | 1738 |
|
|
2018
Q2 | $571K | Sell |
4,956
-291
| -6% | -$31.8K | ﹤0.01% | 1733 |
|
|
2018
Q1 | $451K | Sell |
5,247
-195
| -4% | -$15.1K | ﹤0.01% | 1869 |
|
|
2017
Q4 | $403K | Sell |
5,442
-270
| -5% | -$18.1K | ﹤0.01% | 1968 |
|
|
2017
Q3 | $330K | Hold |
5,712
| – | – | ﹤0.01% | 2118 |
|
|
2017
Q2 | $366K | Buy |
5,712
+676
| +13% | +$41.7K | ﹤0.01% | 2033 |
|
|
2017
Q1 | $290K | Hold |
5,036
| – | – | ﹤0.01% | 2068 |
|
|
2016
Q4 | $308K | Sell |
5,036
-376
| -7% | -$24.5K | ﹤0.01% | 2033 |
|
|
2016
Q3 | $374 | Sell |
5,412
-348
| -6% | -$23K | ﹤0.01% | 1906 |
|
|
2016
Q2 | $321K | Hold |
5,760
| – | – | ﹤0.01% | 1990 |
|
|
2016
Q1 | $350K | Hold |
5,760
| – | – | ﹤0.01% | 1912 |
|
|
2015
Q4 | $368K | Hold |
5,760
| – | – | ﹤0.01% | 1930 |
|
|
2015
Q3 | $386K | Sell |
5,760
-1,840
| -24% | -$130K | ﹤0.01% | 1889 |
|
|
2015
Q2 | $519K | Sell |
7,600
-2,500
| -25% | -$159K | ﹤0.01% | 1903 |
|
|
2015
Q1 | $561K | Hold |
10,100
| – | – | ﹤0.01% | 1848 |
|
|
2014
Q4 | $518K | Hold |
10,100
| – | – | ﹤0.01% | 1906 |
|
|
2014
Q3 | $372K | Hold |
10,100
| – | – | ﹤0.01% | 2101 |
|
|
2014
Q2 | $395K | Hold |
10,100
| – | – | ﹤0.01% | 2154 |
|
|
2014
Q1 | $380K | Hold |
10,100
| – | – | ﹤0.01% | 2176 |
|
|
2013
Q4 | $382K | Hold |
10,100
| – | – | ﹤0.01% | 2153 |
|
|
2013
Q3 | $438K | Hold |
10,100
| – | – | ﹤0.01% | 2005 |
|
|
2013
Q2 | $366K | Buy |
+10,100
| New | +$307K | ﹤0.01% | 2084 |
|
Other funds holding USNA
VOYA Investment Management's USNA Position: Q1 2024 in Review
VOYA Investment Management sold out of Usana Health Sciences (USNA) in Q1 2024, closing a stake of 11,010 shares — an estimated $590K sold.
VOYA Investment Management first reported a position in USNA in Q2 2013 and held it in 43 quarters. The position peaked at $1.14M in Q2 2021. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.
- VOYA Investment Management reported no remaining Usana Health Sciences position as of Q1 2024 after selling out during the quarter.
- VOYA Investment Management sold 11,010 Usana Health Sciences shares in Q1 2024, an estimated $590K.
- VOYA Investment Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 43 quarters.
- VOYA Investment Management's Usana Health Sciences position peaked at $1.14M in Q2 2021.
- 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.
Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.